Further, the distinctly different prognostic roles of cyclin D1 in superficial and muscle-invasive bladder cancers reinforce the concept that urothelial bladder cancer comprises two different diseases with distinct underlying molecular mechanisms [42]. Here, CCND1 is linked to bladder transitional cell carcinoma.